Five hundred and seventy-five patients with various steroid-responsive dermatoses were studied for up to six weeks in eighty-eight separate general practices using a new topical corticosteroid, Temetex (diflucortolone valerate 0·1%). It was concluded that Temetex is both effective and well tolerated in a wide variety of conditions, especially eczema and psoriasis. It was also shown that a large-scale general practice trial can be carried out efficiently with a very high compliance rate.
Get full access to this article
View all access options for this article.
References
1.
BarryWWoodfordR (1974) Comparative bio-availability of proprietary topical corticosteroid preparations. British Journal of Dermatology91, 323
2.
KonzelmannMLuggenHSchwarzKJ (1976) Out-patient evaluation of diflucortolone valerate. Praxis65, 31, 959
3.
LeuF (1976) Comparative dermatological evaluation of two topical corticosteroids. Revue médicale de la Suisse Romande96, 323
4.
LöfflerABainesA (1976) Clinical trial of a new topical corticosteroid diflucortolone valerate in 1191 patients. Pharmatherapeutica1, 305
5.
PlaceVAVelazquezJGVBurdickKH (1970) Precise evaluation of topically applied corticosteroid potency. Archives of Dermatology101, 531
6.
SeifertHW (1976) Topical use of diflucortolone valerate. Arztliche Praxis28, 12, 425
7.
StoughtonRB (1972) Bio-assay system for formulations of topically active glucocorticosteroids. Archives of Dermatology106, 825
